BackDecision Diagnostics Overview

Decision Diagnostics EBIT

Track Decision Diagnostics's EBIT ($-2.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$490.72K
↓ 74.36% YoY

As of Sep 30, 2021

Annual EBIT (TTM)

-$2.10M
↓ 46.5% YoY

Trailing 12 months ending Sep 30, 2021

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Decision Diagnostics (DECN) FAQ

As of the most recent data (September 2021), DECN shows a EBIT of $-2.1M. That compares with $-1.4M in the prior-year period — down 46.5% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DECN's EBIT is now $-2.1M (was $-1.4M) — a 46.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Decision Diagnostics is outperforming or lagging.

The its sector sector average EBIT is about $2.4T. Decision Diagnostics is at $-2.1M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how DECN stacks up against individual peers as well.

Tracking DECN's ebit over time shows whether Decision Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $-2.1M That compares with $-1.4M in the prior-year period — down 46.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Decision Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-2.1M) with ownership activity and broader fundamentals.